Dr. Zhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Elliot Way
Manchester, NH 03103Phone+1 603-627-1669Fax+1 603-624-2297
Education & Training
- Boston University Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2007 - 2008
- Boston University Medical CenterFellowship, Cardiovascular Disease, 2004 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
- Case Western Reserve University School of MedicineClass of 2001
Certifications & Licensure
- NH State Medical License 2008 - 2026
- MA State Medical License 2003 - 2016
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody Marstacimab.Jean Donley, Darshana Jani, Tong Zhu, Yuhong Xiang, Boris Gorovits
The AAPS Journal. 2023-08-23 - 2 citationsSafety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, Arthur Bergman, Tong Zhu
Open Forum Infectious Diseases. 2023-08-01 - 16 citationsA phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.Johnny N Mahlangu, Jose Luis Lamas, Juan Cristobal Morales, Daniel R Malan, Silva Zupančić Šalek
British Journal of Haematology. 2023-01-01
Press Mentions
- Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I StudiesJune 12th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: